Provider
P46-22 eviCore Healthcare Specialty Utilization Management (UM) Program: Medical Oncology Drug Prior Authorization Updates - Opens in a new window
Program effective Date: Aug 01, 2022
Documents & Forms Results
Displaying 1841 - 1850 of 3121 results
Provider
QP61-22 Free Continuing Education for Mental Health Providers through 12/31/22 - Opens in a new window
Program effective Date: Jul 27, 2022
Provider
QP62-22 Commercial Pharmacy Benefit Exclusion for Propel®, Propel Mini®, Sinuva® - Opens in a new window
Program effective Date: Jul 27, 2022
Provider
QP63-22 MHCP Pharmacy Benefit Update – New drug-related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Ryplazim® (plasminogen, human-tvmh) - Opens in a new window
Program effective Date: Jul 27, 2022
Provider
QP55-22 Commercial Pharmacy Benefit Update: New and Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective September 1, 2022 - Opens in a new window
Program effective Date: Jul 13, 2022
Provider
QP56-22 MHCP Pharmacy Benefit Update – New drug-related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Cibinqo™ (abrocitinib) - Opens in a new window
Program effective Date: Jul 13, 2022
Provider
QP57-22 MHCP Pharmacy Benefit Update – New drug-related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Pyrukynd® (mitapivat) - Opens in a new window
Program effective Date: Jul 13, 2022
Provider
QP58-22 MHCP Pharmacy Benefit Update – New drug-related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Recorlev® (levoketoconazole) - Opens in a new window
Program effective Date: Jul 13, 2022
Provider
QP59-22 MHCP Pharmacy Benefit Update – New drug-related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Tarpeyo™ (budesonide) - Opens in a new window
Program effective Date: Jul 13, 2022
Provider
QP60-22 MHCP Pharmacy Benefit Exclusion for Camcevi™ (leuprolide) - Opens in a new window
Program effective Date: Jul 13, 2022